Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Gross Profit Growth Recovery in ProgressRecovering
Percentile Rank50
3Y CAGR-24.5%
5Y CAGR-47.2%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
-24.5%/yr
Annual compound
5Y CAGR
-47.2%/yr
Recent acceleration
Percentile
P50
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | 9.04% |
| 2023 | -17.45% |
| 2022 | -20.51% |
| 2021 | 21.04% |
| 2020 | 20.28% |
| 2019 | 219.38% |
| 2018 | 0.00% |